Form 4: CME Group Director William Shepard Reports Stock Acquisitions

William Shepard, a director at CME Group Inc., reported acquiring shares of Common Stock Class A through a dividend reinvestment plan and the Director Stock Plan.

Summary

• William Shepard, a director of CME Group Inc., filed a Form 4 detailing changes in beneficial ownership.
• On June 25, 2024, Shepard acquired Common Stock Class A through a dividend reinvestment plan at a price of $195.07, resulting in 2,347.826 shares directly owned.
• Additionally, Shepard acquired 1,237 shares of Common Stock Class A at $194.10 through the CME Group Director Stock Plan, bringing the indirectly held shares by trust to 254,891.6443.
• The filing indicates that these transactions were executed pursuant to a dividend reinvestment plan and the CME Group Director Stock Plan.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it reflects a director increasing their stake in the company, which is generally seen as a sign of confidence. However, it's a routine transaction.

Positives

• The acquisition of shares through the dividend reinvestment plan and Director Stock Plan demonstrates Shepard's continued investment in CME Group Inc.

Industry Context

Directors' stock acquisitions are common and often viewed positively, signaling confidence in the company's future performance. These transactions are routine and part of standard compensation and investment strategies.

Comparison to Industry Standards

• Director stock ownership is a common practice across publicly traded companies.
• Many companies offer dividend reinvestment plans and director stock plans to align the interests of management with shareholders.
• The level of ownership is not unusual for a director of a company the size of CME Group.

Stakeholder Impact

• The stock acquisitions could have a slightly positive impact on shareholder confidence.

Key Dates